top of page

PART Trainee Publications

2021

  1. Nalunjogi J, Mugabe F, Najjingo I, Lusiba P, Olweny F, Mubiru J, Kayongo E, Sekibira R, Katamba A, Kirenga B. Accuracy and Incremental Yield of the Chest X-Ray in Screening for Tuberculosis in Uganda: A Cross-Sectional Study. Tuberculosis Research and Treatment. 2021;6
     

  2. Batte C, Namusobya MS, Kirabo R, Mukisa J, Adakun S, Katamba A. Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda. Afri Health Sci. 2021;21(1):238-47. 
     

  3. Kalema N, Semeere A, Banturaki G, Kyamugabwa A, Ssozi S, Ggita J, Kabajaasi O, Kambugu A, Kigozi J, Muganzi A, Castelnuovo B, Cattamanchi A, Armstrong-Hough M. Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis. IJTLD. 2021;25(5):388-394(7).
     

  4. Tusubira AK, Nalwadda CK, Akiteng AR, Hsieh E, Ngaruiya C, Rabin TL, Katahoira A, Hawley NL, Kalyesubula R, Ssinabulya I, Schwartz JI, Armstrong-Hough M. Social Support for Self-Care: Patient Strategies for Managing Diabetes and Hypertension in Rural Uganda. Annals of Global Health. 2021;87(1):86
     

  5. Musisi E, Dide-Agossou C, Al Mubarak R, Rossmassler K, Ssesolo AW, Kaswabuli S, Byanyima P, Sanyu I, Zawedde J, Worodria W, Voskuil MI, Savic RM, Nahid P, David JL, Huang L, Moore CM, Walter ND. Reproducibility of the Ribosomal RNA Synthesis Ratio in Sputum and Association with Markers of Mycobacterium tuberculosis Burden. ASM. 2021;9(2):e00481-21
     

  6. Bakamutumaho B, Cummings MJ, Owor N, Kayiwa J, Namulondo J, Byaruhanga T, Muwanga M, Nsereko C, Rwamutwe E, Mutonyi R, Achan J, Wanyenze L, Ndazarwe A, Nakanjako R, Natuhwera R, Nsangi A, Bosa HK, Ocom F, O'Donnell MR, Kikaire B, Lutwama JL. Severe COVID-19 in Uganda across Two Epidemic Phases: A Prosepctive Cohort Study. Am J Trop Med Hyg. 2021 Aug;105(3):740-744.
     

  7. Ddungu A, Semitala FC, Castelnuovo B, Sekaggya-Wiltshire C, Worodria W, Kirenga BJ. Chronic obstructive pulmonary disease prevalence and associated factors in an urban HIV clinic in a low income country. PLoS ONE. 2021 Aug;16(8):e0256121. doi: 10.1371/journal.pone.0256121
     

  8. Uwimaana E, Bagaya BS, Castelnuovo B, Kateete DP, Anguzu G, Kiwanuka N, Whalen CC, Joloba ML. Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study. BMC Infect Dis. 2021 Jul;21(1):711. doi: 10.1186/s12879-021-06370-7
     

  9. Jaganath D, Wambi P, Reza TF, Nakafeero J, Aben EO, Kiconco E, Nannyonga G, Nsereko M, Sekadde MP, Mudiope M, Kato-Maeda M, Starke J, Andama A, Mohanty S, Wobudeya E, Cattamanchi A. A Prospective Evaluation of Xpert MTB/RIF Ultra for Childhood Pulmonary Tuberculosis in Uganda. J Pediatric Infect Dis Soc. 2021 May;10(5):586-592 doi: 10.1093/jpids/piaa159.

DSC_0793.JPG
DSC_0763.JPG

2020

  1. Nalugwa T, Shete PB, Nantale M, Farr K, Ojok C, Ochom E, Mugabe F, Joloba M, Dowdy DW, Moore DAJ, Davis JL, Cattamanchi A, Katamba A. Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective. BMC Health Serv Res. 2020;20(1):162-.
     

  2. Musiimenta A, Tumuhimbise W, Atukunda EC, Mugaba AT, Muzoora C, Armstrong-Hough M, Bangsberg D, Davis JL, Haberer JE. Mobile Health Technologies May Be Acceptable Tools for Providing Social Support to Tuberculosis Patients in Rural Uganda: A Parallel Mixed-Method Study. Tuberc Res Treat. 2020;2020:7401045.
     

  3. Naluyange, R., Mboowa, G., Komakech, K., Semugenze, D., Kateete, D. P., & Ssengooba, W. (2020). High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda. PLOS ONE, 15(5), e0232543. 
     

  4. Batte C, Olayanju T, Mukisa J, Namusobya MS, Alenoghena I, Sulaiman L, Tazifua EA, Oladela D, Morton B. The accuracy of a mobile phone application (Wulira app) compared to standard audiometry in assessing hearing loss among patients on treatment for multi-drug resistant tuberculosis in Uganda. J Pan Afr Thorac Soc 2020;1(1):20-5. 

2019

  1. Farr K, Nalugwa T, Ojok C, Nantale M, Nabwire S, Oyuku D, Shete P, Han A, Fielding K, Joloba M, Mugabe F, Dowdy DW, Moore DAJ, Davis JL, Katamba A, Cattamanchi A. Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2019;15:100099. 
     

  2. Davis JL, Turimumahoro P, Meyer AJ, Ayakaka I, Ochom E, Ggita J, Mark D, Babirye D, Okello DA, Mugabe F, Fair E, Vittinghoff E, Armstrong-Hough M, Dowdy D, Cattamanchi A, Haberer JE, Katamba A. Home-based tuberculosis contact investigation in Uganda: a household randomized trial. ERJ Open Research. 2019;5:00112-2019. 
     

  3. Babirye D, Shete PB, Farr K, Nalugwa T, Ojok C, Nantale M, Oyuku D, Ayakaka I, Katamba A, Davis JL, Nadunga D, Joloba M, Moore D, Cattamanchi A. Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2019;16:100110. 
     

  4. Wood A, Barizuddin S, Darr C, Mathai C, Ball A, Minch K, Somoskovi A, Hamasur B, Connelly JT, Weigl B, Andama A, Cattamanchi A, Gangopadhyay K, Bok S, Gangopadhyay S. Ultrasensitive dection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of HIV negative patients with tuberculosis. PLOS ONE. 2019;14(3):e021416.
     

  5. Andama A, Somoskovi A, Mandel B, Bell D, Gutierrez C. Improving diagnosis and case management of patients with tuberculosis: A review of gaps, needs and potential solutions in accessing laboratory diagnostics. Infection, Genetics and Evolution. 2019; 72:131-140.
     

  6. Yoon C, Semitala F, Asege L, Katende J, Mwebe S, Andama A, Atuhumuza E, Nakaye M, Armstrong DT, Dowdy DW, McCulloch CE, Kamya M, Cattamanchi A. Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV. Am J Respir Crit Care Med. 2019; 199(5):643-650.
     

  7. Wang S, Chang E, Byanyima P, Huang P, Sanyu I, Musisi E, Sessolo A, Davis JL, Worodria W, Huang L, Lin J, Inflammation, Aging Microbes and Obstructive Lung Disease Study. Association between common telomere length genetic variants and telomere length in an African population and impacts of HIV and TB. J Hum Genet. 2019;64(10):1033-1040. 
     

  8. Wang RJ, Moore J, Moisi D, Chang EG, Byanyima P, Kaswabuli S, Musisi E, Sanyu I, Sessolo A, Lalitha R, Worodria W, Davis JL, Crothers K, Lin J, Lederman MM, Hunt PW, Huang L. HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia. PLoS One. 2019;14(5):e0216680. 
     

  9. Shenoy MK, Fadrosh DW, Lin DL, Worodria W, Byanyima P, Musisi E, Kaswabuli S, Zawedde J, Sanyu I, Chang E, Fong S, McCauley K, Davis JL, Huang L, Lynch SV. Gut microbiota in HIV-pneumonia patients is related to peripheral CD4 counts, lung microbiota, and in vitro macrophage dysfunction. Microbiome. 2019;7(1):37. 
     

  10. Kendall EA, Kamoga C, Kitonsa PJ, Nalutaaya A, Salvatore PP, Robsky K, Nakasolya O, Mukibi J, Isooba D, Cattamanchi A, Kato-Maeda M, Katamba A, Dowdy DW. Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF and clinical diagnoses. PLoS One. 2019;14(7):e0220251
     

  11. Andama A, Jaganath D, Crowder R, Asege L, Nakaye M, Katumba D, Mwebe S, Semitala F, Worodria W, Joloba M, Mohanty S, Somoskovi A, Cattamanchi A. Accuracy and incremental yield of urine Xpert MTB/RIF Ultra versus Determine TB-LAM for diagnosis of pulmonary tuberculosis. Diagnostic Microbiology and Infectious Disease. 2019; 
     

  12. Musiimenta A, Tumuhimbise W, Mugaba AT, Muzoora C, Armstrong-Hough M, Bangsberg D, Davis JL, Haberer JE. Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study. J Clin Tuberc Other Mycobact Dis. 2019;17:100119.

2018

  1. White EB, Meyer AJ, Ggita JM, Babirye D, Mark D, Ayakaka I, Haberer JE, Katamba A, Armstrong-Hough M, Davis JL. Feasibility, Acceptability, and Adoption of Digital Fingerprinting During Contact Investigation for Tuberculosis in Kampala, Uganda: A Parallel-Convergent Mixed-Methods Analysis. J Med Internet Res. 2018;20(11):e11541.
     

  2. Musisi E, Matovu DK, Bukenya A, Kaswabuli S, Zawedde J, Andama A, Byanyima P, Sanyu I, Sessolo A, Seremba E, Davis JL, Worodria W, Huang L, Walter ND, Mayanja-Kizza H. Effect of anti-retroviral therapy on oxidative stress in hospitalized HIV-infected adults with and without TB. Afr Health Sci. 2018;18(3):512-22. PMID: 30602982; PMCID: PMC6306996.
     

  3. Meyer AJ, Babirye D, Armstrong-Hough M, Mark D, Ayakaka I, Katamba A, Haberer JE, Davis JL. Text Messages Sent to Household Tuberculosis Contacts in Kampala, Uganda: Process Evaluation. JMIR Mhealth Uhealth. 2018;6(11):e10239.
     

  4. Farr K, Ravindran R, Strnad L, Chang E, Chaisson LH, Yoon C, Worodria W, Andama A, Ayakaka I, Bbosa Nalwanga P, Byanyima P, Kalema N, Kaswabuli S, Katagira W, Aman KD, Musisi E, Tumwine NW, Sanyu I, Ssebunya R, Davis JL, Huang L, Khan IH, Cattamanchi A. Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV. PLoS ONE. 2018; 13(10):e0206119. PMID: 30352099
     

  5. Kizito S, Katamba A, Marquez C, Turimumahoro P, Ayakaka I, Davis JL, Cattamanchi A. Quality of care in childhood tuberculosis diagnosis at primary care clinics in Kampala, Uganda. Int J Tuberc Lung Dis. 2018;22(10):1196-202. PMID: 30236188.
     

  6. Andama A, Somoskovi A, Mandel B, Bell D, Gutierrez C. Improving diagnosis and case management of patients with tuberculosis: A review of gaps, needs and potential solutions in accessing laboratory diagnostics. Infect Genet Evol. 2018. PMID: 30326281.
     

  7. Kirenga BJ, Mugenyi L, de Jong C, Davis JL, Katagira W, van der Molen T, Kamya MR, Boezen M. The impact of HIV on the prevalence of asthma in Uganda: a general population survey. Respir Res. 2018;19(1):184. PMID: 30241519.
     

  8. Ggita JM, Ojok C, Meyer AJ, Farr K, Shete PB, Ochom E, Turimumahoro P, Babirye D, Mark D, Dowdy D, Ackerman S, Armstrong-Hough M, Nalugwa T, Ayakaka I, Moore D, Haberer JE, Cattamanchi A, Katamba A, Davis JL. Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. The International Journal of Tuberculosis and Lung Disease. 2018;22(5):530-6. PMID: 29663958.
     

  9. Armstrong-Hough M, Ggita J, Turimumahoro P, Meyer AJ, Ochom E, Dowdy D, Cattamanchi A, Katamba A, Davis JL. 'Something so hard': a mixed-methods study of home sputum collection for tuberculosis contact investigation in Uganda. Int J Tuberc Lung Dis. 2018;22(10):1152-9. PMID: 30236182.
     

  10. Ggita JM, Ojok C, Meyer AJ, Farr K, Shete PB, Ochom E, Turimumahoro P, Babirye D, Mark D, Dowdy D, Ackerman S, Armstrong-Hough M, Nalugwa T, Ayakaka I, Moore D, Haberer JE, Cattamanchi A, Katamba A, Davis JL. Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. The International Journal of Tuberculosis and Lung Disease. 2018;22(5):530-6. PMID: 29663958.
     

  11. Ochom E, Meyer AJ, Armstrong-Hough M, Kizito S, Ayakaka I, Turimumahoro P, Ggita JM, Katamba A, Davis JL. Integrating home HIV counselling and testing into household TB contact investigation: a mixed-methods study. Public Health Action. 2018;8(2):72-8. PMID: 29946523; PMCID: PMC6012957.
     

  12. Armstrong-Hough M, Ggita J, Ayakaka I, Dowdy D, Cattamanchi A, Haberer JE, Katamba A, Davis JL. Brief Report: "Give Me Some Time": Facilitators of and Barriers to Uptake of Home-Based HIV Testing During Household Contact Investigation for Tuberculosis in Kampala, Uganda. J Acquir Immune Defic Syndr. 2018;77(4):400-4. PMID: 29300218; PMCID: PMC5825267.
     

  13. Wayengera M, Kateete DP, Asiimwe B, Joloba ML. Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection. BMC infectious diseases. 2018;18(1):133.
     

  14. Worodria W, Chang E, Andama A, Sanyu I, Byanyima P, Musisi E, Kaswabuli S, Zawedde J, Ayakaka I, Sessolo A, Lalitha R, Davis JL, Huang L. Predictors of Mortality Among Hospitalized Patients With Lower Respiratory Tract Infections in a High HIV Burden Setting. J Acquir Immune Defic Syndr. 2018;79(5):624-630. PMID: 30222660

2017

  1. Wayengera M, Mwebaza I, Welishe J, Bayiyana A, Kateete DP, Wampande E, Kirimunda S, Kigozi E, Katabazi F, Musubika C, Kyobe S, Babirye P, Asiimwe B, Joloba ML. Immuno-diagnosis of Mycobacterium tuberculosis in sputum, and reduction of timelines for its positive cultures to within 3 h by pathogen-specific thymidylate kinase expression assays. BMC research notes. 2017;10(1):368; PMCID: PMC5549350.
     

  2. Wayengera M, Mwebaza I, Welishe J, Nakimuli C, Kateete DP, Wampande E, Kirimunda S, Bayigga L, Musubika C, Babirye P, Asiimwe B, Joloba ML. Sero-diagnosis of Active Mycobacterium tuberculosis Disease among HIV Co-infected Persons using Thymidylate Kinase based Antigen and Antibody Capture Enzyme Immuno-Assays. Mycobacterial diseases: tuberculosis & leprosy. 2017;7(2). PMID: 28856068; PMCID: PMC5573238.
     

  3. Meyer AJ, Atuheire C, Worodria W, Kizito S, Katamba A, Sanyu I, Andama A, Ayakaka I, Cattamanchi A, Bwanga F, Huang L, Davis JL. Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda. PLoS One. 2017;12(7):e0180572. PMID: 28686705; PMCID: PMC5501569 
     

  4. Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, Fair E, Hopewell P, Handley MA, Cattamanchi A, Katamba A, Davis JL. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach. Implementation science : IS. 2017;12(1):33. PMID: 28274245; PMCID: PMC5343292.
     

  5. Kalema N, Lindan C, Glidden D, Yoo SD, Katamba A, Andama A, Katagira W, Byanyima P, Musisi E, Kaswabuli S, Ingvar S, Zawedde J, Yoon C, Ayakaka I, Davis JL, Huang L, Worodria W, Cattamanchi A. Predictors and short-term outcomes of recurrent pulmonary tuberculosis, Uganda: a cohort study. S Afr Respir J. 2017;23(4):106-112. PMID: 29368752
     

  6. Cummings MJ, Goldberg E, Mwaka S, Kabajaasi O, Vittinghoff E, Cattamanchi A, Katamba A, Kenya-Mugisha N, Jacob ST, Davis JL. A complex intervention to improve implementation of World Health Organization guidelines for diagnosis of severe illness in low-income settings: a quasi-experimental study from Uganda. Implement Sci. 2017; 12(1):126. PMID:29110667

2016 and beyond 

  1. Kirenga BJ. Rapid assessment of the demand and supply of tobacco dependence pharmacotherapy in Uganda. Public Health Action. 2016;6(1):35-7. PMID: 27051610; PMCID: PMC4809727.
     

  2. Katagira W, Walter ND, den Boon S, Kalema N, Ayakaka I, Vittinghoff E, Worodria W, Cattamanchi A, Huang L, Davis JL. Empiric TB treatment of severely ill patients with HIV and presumed pulmonary TB improves survival. J Acquir Immune Defic Syndr. 2016;72(3):297-303. PMID: 26918546; PMCID: 5108656.
     

  3. Hsiang E, Little KM, Haguma P, Hanrahan CF, Katamba A, Cattamanchi A, Davis JL, Vassall A, Dowdy D. Higher cost of implementing Xpert((R)) MTB/RIF in Ugandan peripheral settings: implications for cost-effectiveness. Int J Tuberc Lung Dis. 2016;20(9):1212-8. PMID: 27510248; PMCID: 5018405.
     

  4. Hanrahan CF, Haguma P, Ochom E, Kinera I, Cobelens F, Cattamanchi A, Davis L, Katamba A, Dowdy D. Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis. Open Forum Infectious Diseases. 2016;3(2); PMCID: 4866550.
     

  5. Kizito S, Mukunya D, Nakitende J, Nambasa S, Nampogo A, Kalyesubula R, Katamba A, Sewankambo N. Career intentions of final year medical students in Uganda after graduating: the burden of brain drain. BMC medical education. 2015;15(1):122; PMCID: PMC4522140 
     

  6. Semitala FC, Chaisson LH, Boon Sd, Walter N, Cattamanchi A, Awor M, Katende J, Huang L, Joloba M, Albert H, Kamya MR, Davis JL. Impact of mycobacterial culture among HIV-infected adults with presumed TB in Uganda: a prospective cohort study. Public Health Action. 2015;5(2):106-11; PMCID: 4487479.
     

  7. Ross JM, Cattamanchi A, Miller CR, Tatem AJ, Katamba A, Haguma P, Handley MA, Davis JL. Investigating barriers to tuberculosis evaluation in Uganda using geographic information systems. Am J Trop Med Hyg. 2015;93(4):733-8. PMID: 26217044; PMCID: 4596591.
     

  8. Chaisson LH, Katamba A, Haguma P, Ochom E, Ayakaka I, Mugabe F, Miller C, Vittinghoff E, Davis JL, Handley MA, Cattamanchi A. Theory-informed interventions to improve the quality of tuberculosis evaluation at Ugandan health centers: a quasi-experimental study. PLoS ONE. 2015;10(7):e0132573; PMCID: 4501843.
     

  9. Okwera A, Bwanga F, Najjingo I, Mulumba Y, Mafigiri DK, Whalen CC, Joloba ML. Aetiology of pulmonary symptoms in HIV-infected smear negative recurrent PTB suspects in Kampala, Uganda: a cross-sectional study. PLoS One. 2013;8(12):e82257. PMID: 24312650; PMCID: PMC3849471.
     

  10. Andama AO, den Boon S, Meya D, Cattamanchi A, Worodria W, Davis JL, Walter ND, Yoo SD, Kalema N, Haller B, Huang L. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda. J Acquir Immune Defic Syndr. 2013;63(2):189-94. PMID: 23542636; PMCID: 3779784.

bottom of page